Professional Documents
Culture Documents
Guidelines For Dosing of Some Commonly Used Cepha
Guidelines For Dosing of Some Commonly Used Cepha
Bertram G. Katzung+
TABLE 43–2Guidelines for dosing of some commonly used cephalosporins and other cell-wall inhibitor antibiotics.
Antibiotic (Route of Adjusted Dose as a Percentage of Normal Dose for Renal Failure
Adult Dose Pediatric Dose1 Neonatal Dose2
Administration) Based on Creatinine Clearance (Clcr)
Clcr Approx 50 mL/min Clcr Approx 10 mL/min
First-generation cephalosporins
Second-generation cephalosporins
Third- and fourth-generation cephalosporins including ceftaroline fosamil
100–150 mg/kg/d in 2 or 3
Ceftazidime (IV) 1–2 g q8–12h 75–150 mg/kg/d in 3 doses 50% 25%
doses
75–120 mg/kg/d in 2 or 3
Cefepime (IV) 0.5–2 g q12h 50% 25%
divided doses
Cephalosporin–β-lactamase inhibitor combinations
Carbapenems
60–120 mg/kg/d in 3 doses
Meropenem (IV) 1 g q8h (2 g q8h for meningitis) 66% 50%
(maximum of 2 g q8h)
Glycopeptides
15 mg/kg load, then 20 mg/kg/d
Vancomycin (IV) 30–60 mg/kg/d in 2–3 doses 40 mg/kg/d in 3 or 4 doses 40% 10%
in 2 doses
1000 mg on day 1, 500 mg day
Dalbavancin (IV) 8 None >30 mL/min 75%
Alternative: 1500 mg × 1
Lipopeptides (IV)
The total dose should not exceed the adult dose.
2
The dose shown is during the first week of life. The daily dose should be increased by approximately 33–50% after the first week of life. The lower dosage range should be used for neonates weighing less than 2
kg. After the first month of life, pediatric doses may be used.
3
50% of dose for Clcr <30 mL/min.
Date of download: 09/16/20 from AccessPharmacy: accesspharmacy.mhmedical.com, Copyright © McGraw Hill. All rights reserved.